Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial - Choi, Yoon Jin; Lee, Yong Chan; Kim, Jung Mogg; Kim, Jin Il; Moon, Jeong Seop; Lim, Yun Jeong; Baik, Gwang Ho; Son, Byoung Kwan; Lee, Hang Lak; Kim, Kyoung Oh; Kim, Nayoung; Ko, Kwang Hyun; et al. (Gut and liver, 2022)
Keywords: helicobacter pylori; Original; potassium-competitive acid blocker; tegoprazan; 내과학